There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annovis Bio (ANVS – Research Report) and Centogene NV (CNTG – Research Report) with bullish sentiments.
Annovis Bio (ANVS)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Annovis Bio, with a price target of $40.00. The company’s shares closed last Tuesday at $14.26.
According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Annovis Bio is a Moderate Buy with an average price target of $33.00.
See today’s best-performing stocks on TipRanks >>
Centogene NV (CNTG)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Centogene NV today and set a price target of $1.50. The company’s shares closed last Tuesday at $1.18.
According to TipRanks.com, Chen ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Centogene NV with a $1.50 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ANVS:
